TrialMolecular oncology2014

Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment.

J B Kjersem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.